Philip Tagari is a seasoned Chief Scientific Officer with a strong background in drug discovery and research. With over a decade of experience at Amgen Inc, he has successfully advanced numerous innovative molecules into clinical development and commercialization. Philip's expertise lies in redefining disease biology and implementing novel approaches to accelerate the delivery of therapeutics to p...